Literature DB >> 7400319

X-linked inheritance in females with chronic granulomatous disease.

E L Mills, K S Rholl, P G Quie.   

Abstract

Chronic granulomatous disease in males is familial and its transmission is is usually clearly x-linked. The mode of inheritance in females with the syndrome is unknown and the carrier state difficult to identify. Defective polymorphonuclear leukocyte bactericidal activity in this disease is associated with an absence of the respiratory burst generated in stimulated phagocytes and may be detected by the chemiluminescence assay. Polymorphonuclear leukocytes from three of four females with chronic granulomatous disease had extremely low chemiluminescence production, their asymptomatic mothers had intermediate values, and their fathers were normal. Polymorphonuclear neutrophils of two affected males in these kinships generated no chemiluminescence, whereas two of seven female relatives had intermediate values, and all nonaffected males had normal values. In the three families in which leukocytes were studied by nitroblue tetrazolium reduction, two populations of neutrophils were demonstrated for the female patients and/or their mothers. The wide phenotypic variability for clinical disease, evidence of two leukocyte populations in the patients or their mothers, and low but detectable leukocyte chemiluminescence in the affected females is consistent with the Lyon hypothesis of x-chromosome inactivation in these families. The findings suggest an x-linked inheritance in these females with chronic granulomatous disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7400319      PMCID: PMC371715          DOI: 10.1172/JCI109861

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages.

Authors:  R C Allen; L D Loose
Journal:  Biochem Biophys Res Commun       Date:  1976-03-08       Impact factor: 3.575

2.  Defective initiation of oxidative metabolism in polymorphonuclear leukocytes.

Authors:  L Harvath; B R Andersen
Journal:  N Engl J Med       Date:  1979-05-17       Impact factor: 91.245

Review 3.  Chronic granulomatous disease.

Authors:  R B Johnston; S L Newman
Journal:  Pediatr Clin North Am       Date:  1977-05       Impact factor: 3.278

4.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

5.  Gastric antral narrowing in chronic granulomatous disease of childhood.

Authors:  N T Griscom; J A Kirkpatrick; B R Girdany; W E Berdon; R J Grand; G G Mackie
Journal:  Pediatrics       Date:  1974-10       Impact factor: 7.124

6.  Letter: NBT results in chronic granulomatous disease.

Authors:  H Wilson; W M Larson; D I Webb
Journal:  J Pediatr       Date:  1974-02       Impact factor: 4.406

7.  Functional studies on human peritoneal eosinophils.

Authors:  S J Klebanoff; D T Durack; H Rosen; R A Clark
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

8.  Biological defense mechanisms. The effect of bacteria and serum on superoxide production by granulocytes.

Authors:  J T Curnutte; B M Babior
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

9.  Absence of a newly described cytochrome b from neutrophils of patients with chronic granulomatous disease.

Authors:  A W Segal; O T Jones; D Webster; A C Allison
Journal:  Lancet       Date:  1978-08-26       Impact factor: 79.321

10.  Generation of superoxide anion and chemiluminescence by human monocytes during phagocytosis and on contact with surface-bound immunoglobulin G.

Authors:  R B Johnston; J E Lehmeyer; L A Guthrie
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

View more
  17 in total

1.  Oxidative response of human neutrophils, monocytes, and alveolar macrophages induced by unopsonized surface-adherent Staphylococcus aureus.

Authors:  M L Devalon; G R Elliott; W E Regelmann
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

Review 2.  Prenatal diagnosis and carrier detection in primary immunodeficiency disorders.

Authors:  Y L Lau; R J Levinsky
Journal:  Arch Dis Child       Date:  1988-07       Impact factor: 3.791

3.  Chemiluminescent response of polymorphonuclear leukocytes to Streptococcus pneumoniae and Haemophilus influenzae in suspension and adhered to glass.

Authors:  K Hayashi; D A Lee; P G Quie
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

4.  Extrapulmonary abscess formation due to Pseudomonas cepacia in a cystic fibrosis patient.

Authors:  J M Langley; E L Ford-Jones; D C Armstrong; R Gold; S Read; H Levison
Journal:  Can J Infect Dis       Date:  1993-07

5.  Nonopsonic phagocytosis of strains of Pseudomonas aeruginosa from cystic fibrosis patients.

Authors:  D P Speert; F Eftekhar; M L Puterman
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

6.  Chemiluminescence by polymorphonuclear leukocytes adhering to surfaces.

Authors:  M Yanai; P G Quie
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

7.  Cerebral aspergilloma in a child with autosomal recessive chronic granulomatous disease.

Authors:  A F Dean; I Janota; A Thrasher; I Robertson; G Mieli-Vergani
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

8.  Use of an X-linked human neutrophil marker to estimate timing of lyonization and size of the dividing stem cell pool.

Authors:  E S Buescher; D W Alling; J I Gallin
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

Review 9.  The molecular basis of chronic granulomatous disease.

Authors:  C Meischl; D Roos
Journal:  Springer Semin Immunopathol       Date:  1998

10.  Abnormal regulation of inflammatory skin responses in male patients with chronic granulomatous disease.

Authors:  J I Gallin; E S Buescher
Journal:  Inflammation       Date:  1983-09       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.